| 000 | 01623 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513061428.0 | ||
| 264 | 0 | _c19931008 | |
| 008 | 199310s 0 0 eng d | ||
| 022 | _a0959-4965 | ||
| 024 | 7 |
_a10.1097/00001756-199307000-00022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBatini, C | |
| 245 | 0 | 0 |
_aCytoplasmic calcium buffer, calbindin-D28k, is regulated by excitatory amino acids. _h[electronic resource] |
| 260 |
_bNeuroreport _cJul 1993 |
||
| 300 |
_a927-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a6-Cyano-7-nitroquinoxaline-2,3-dione |
| 650 | 0 | 4 |
_aAmino Acids _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCalbindin 1 |
| 650 | 0 | 4 | _aCalbindins |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCerebellar Cortex _xcytology |
| 650 | 0 | 4 |
_aCytoplasm _xdrug effects |
| 650 | 0 | 4 | _aExcitatory Amino Acid Antagonists |
| 650 | 0 | 4 |
_aGlutamates _xpharmacology |
| 650 | 0 | 4 | _aGlutamic Acid |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aKainic Acid _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPurkinje Cells _xdrug effects |
| 650 | 0 | 4 |
_aQuinoxalines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aS100 Calcium Binding Protein G _xmetabolism |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 700 | 1 | _aPalestini, M | |
| 700 | 1 | _aThomasset, M | |
| 700 | 1 | _aVigot, R | |
| 773 | 0 |
_tNeuroreport _gvol. 4 _gno. 7 _gp. 927-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00001756-199307000-00022 _zAvailable from publisher's website |
| 999 |
_c8103009 _d8103009 |
||